Vasopressin antagonism in heart failure: a review of the hemodynamic studies and major clinical tria...
Vasopressin antagonism in heart failure: a review of the hemodynamic studies and major clinical trials
About this item
Full title
Author / Creator
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
For decades, plasma arginine vasopressin (AVP) levels have been known to be elevated in patients with congestive heart failure (HF). Excessive AVP signaling at either or both the V1a and V2 receptors could contribute to the pathophysiology of HF by several mechanisms. V1a activation could cause vasoconstriction and/or direct myocardial hypertrophy...
Alternative Titles
Full title
Vasopressin antagonism in heart failure: a review of the hemodynamic studies and major clinical trials
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_05f1b7f030a54f02ba0651d72644213b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_05f1b7f030a54f02ba0651d72644213b
Other Identifiers
ISSN
1753-9447
E-ISSN
1753-9455
DOI
10.1177/1753944720977741
